CN Patent

CN101801346A — 抗失眠症组合物及方法

Assigned to Flemington Pharmaceutical Corp · Expires 2010-08-11 · 16y expired

What this patent protects

唑吡旦组合物及其制备方法以及治疗失眠症的用途。组合物配制为用于唑吡旦跨粘膜吸收的口腔喷雾剂。在一些情况下，所述治疗方法涉及夜间按剂量给药，以实现在20分钟之内达到治疗性唑吡旦的血液水平，在给药后不到5小时、在一些情况下不到4小时之内逐渐减少至低于20ng/ml。

USPTO Abstract

唑吡旦组合物及其制备方法以及治疗失眠症的用途。组合物配制为用于唑吡旦跨粘膜吸收的口腔喷雾剂。在一些情况下，所述治疗方法涉及夜间按剂量给药，以实现在20分钟之内达到治疗性唑吡旦的血液水平，在给药后不到5小时、在一些情况下不到4小时之内逐渐减少至低于20ng/ml。

Drugs covered by this patent

Patent Metadata

Patent number
CN101801346A
Jurisdiction
CN
Classification
—
Expires
2010-08-11
Drug substance claim
No
Drug product claim
No
Assignee
Flemington Pharmaceutical Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.